The anticholinergic risk scale and anticholinergic adverse effects in older persons.

By J. Rudolph, Marci J. Salow, Michael C. Angelini, R. McGlinchey. Archives of Internal Medicine, 2008

799 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Geriatrics and Gerontology, Toxicology

View Paper: https://www.semanticscholar.org/paper/13bb7f7e674cbd940227a46dc77b5fc65c8f5c7f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Bhattacharyya
2. Samuel P. Gubbels
3. T. Fife
4. S. Schwartz
5. J. Edlow
6. H. El‐Kashlan
7. B. Do
8. J. Holmberg

Citations in the corpus

• Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (2008, background): “In addition, there is evidence of additional potential harm from the antihistamine class of medications on cognitive functioning,(186) and on gastrointestinal motility, urinary retention, vision, and dry mouth in the elderly.(197) In summary, vestibular suppressant medications are not recommended fo”
• Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) (2017, background): “In addition, there is evidence of additional potential harm from the antihistamine class of medications on cognitive functioning(235) and on gastrointestinal motility, urinary retention, vision, and dry mouth in the elderly.(244) There is no evidence in the literature to suggest that any of these ve”